RecruitingNot ApplicableNCT04629326

PD-L1 Targeting Molecular Imaging of Solid Tumors

Sponsor

Peking University Cancer Hospital & Institute

Enrollment

20 participants

Start Date

Jul 20, 2021

Study Type

INTERVENTIONAL

Conditions

Gastrointestinal Tumors

Summary

The objective of the study is to constrcut a noninvasive approach WL12 PET/CT to detect the PD-L1 expression of tumor lesions in patients with gastrointestinal tumors and to identify patients benefiting from anti-PD-1/L1 treatment.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

\. Aged \>18 years old; ECOG 0 or 1;
\. Patients with Gastrointestinal tumors;
\. Has at least one measurable target lesion according to Response Evaluation Criteria in Solid Tumors (RECIST V1.1);
\. life expectancy \>=12 weeks.

Exclusion Criteria6

\. Significant hepatic or renal dysfunction;
\. Is pregnant or ready to pregnant;
\. Cannot keep their states for half an hour;
\. Refusal to join the clinical study;
\. Suffering from claustrophobia or other mental diseases;
\. Any other situation that researchers think it is not suitable to participate in the experiment.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.